Norges Bank Makes New $40.01 Million Investment in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Norges Bank acquired a new stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 512,339 shares of the company’s stock, valued at approximately $40,009,000. Norges Bank owned approximately 1.04% of Prestige Consumer Healthcare at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. JPMorgan Chase & Co. raised its position in Prestige Consumer Healthcare by 3.2% during the third quarter. JPMorgan Chase & Co. now owns 272,255 shares of the company’s stock worth $19,630,000 after acquiring an additional 8,533 shares during the period. Geode Capital Management LLC lifted its stake in Prestige Consumer Healthcare by 4.0% in the 3rd quarter. Geode Capital Management LLC now owns 1,326,794 shares of the company’s stock valued at $95,678,000 after buying an additional 50,961 shares in the last quarter. Avior Wealth Management LLC boosted its holdings in Prestige Consumer Healthcare by 1,570.7% in the 4th quarter. Avior Wealth Management LLC now owns 8,554 shares of the company’s stock worth $668,000 after buying an additional 8,042 shares during the last quarter. Charles Schwab Investment Management Inc. raised its holdings in shares of Prestige Consumer Healthcare by 5.6% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 636,020 shares of the company’s stock valued at $49,667,000 after acquiring an additional 33,844 shares during the last quarter. Finally, Barclays PLC lifted its position in shares of Prestige Consumer Healthcare by 346.3% in the third quarter. Barclays PLC now owns 92,444 shares of the company’s stock valued at $6,665,000 after acquiring an additional 71,730 shares in the last quarter. 99.95% of the stock is owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Stock Down 2.0 %

Shares of NYSE PBH opened at $82.85 on Friday. Prestige Consumer Healthcare Inc. has a 1 year low of $62.35 and a 1 year high of $90.04. The company has a market capitalization of $4.10 billion, a P/E ratio of 19.40, a P/E/G ratio of 2.69 and a beta of 0.46. The company has a 50 day simple moving average of $84.03 and a 200-day simple moving average of $79.44. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.20.

Prestige Consumer Healthcare (NYSE:PBH) last posted its earnings results on Thursday, February 6th. The company reported $1.22 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. On average, equities research analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms recently commented on PBH. StockNews.com raised Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research note on Tuesday, March 18th. Royal Bank of Canada raised their price target on shares of Prestige Consumer Healthcare from $96.00 to $97.00 and gave the stock a “sector perform” rating in a research note on Friday, March 21st. Sidoti cut shares of Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price objective for the company. in a research note on Monday, December 9th. Raymond James upgraded Prestige Consumer Healthcare to a “moderate buy” rating in a report on Thursday, December 19th. Finally, Canaccord Genuity Group increased their price target on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a “buy” rating in a report on Friday, February 7th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Prestige Consumer Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $93.33.

Insiders Place Their Bets

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of the business’s stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $90.00, for a total value of $151,020.00. Following the sale, the senior vice president now owns 17,157 shares of the company’s stock, valued at $1,544,130. The trade was a 8.91 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.60% of the stock is currently owned by insiders.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.